NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation drugs for CNS indications, announced today that it has closed on $500,000 in seed funding.
“This is a significant step toward achieving our goal of accessing $2MM in seed funding. Two million dollars in seed funding combined with the $1.6MM the company has been awarded […]
Archive for the 'Deals' Category
Allylix, Inc., a natural and fine chemical company, today announced that the company has successfully secured $1.5 million in capital and appointed Carolyn Fritz, M.B.A., as its new CEO. The financing will be used to fund the development and scale-up of its first products. The close of this round of funding was lead by President […]
